Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Synoste Oy
Work at Synoste Oy?
Add yourself to this profile
94
Synoste Oy
Synoste develops next-generation medical solutions for the treatment and correction of skeletal deformities. Its implants for lengthening limbs are based on a mechanism using smart metals that operate safely and painlessly for the patient.
Edit Profile
synoste.com
Health Care
>
Medical
>
Medical Devices
B2c
Founded in
2012
More info
Elsewhere
Companies in the same industry
NeuralNavigator
AdhereTech
Mimi
baebies
Aviacode
HistoSonics
nContact, Inc.
Ovizio
Nexeon Medsystems
Daktari Diagnostics
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
Venture capital
Evonik Venture Capital GmbH
Venture capital (Series A)
$2,200,000
Finnvera Venture Capital
,
Lifeline Ventures
,
High-Tech Grunderfonds
, +3
Employees
Team size
2
Locations
HQ
Finland
Headquarters
$2,200,000
Venture capital (Series A)
High-Tech Gründerfonds
Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant for correcting skeletal deformities
Venture capital
evonik
Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki Industries - Specialty Chemicals
NeuralNavigator
AdhereTech
Mimi
baebies
Aviacode
HistoSonics
Ovizio
Nexeon Medsystems
Daktari Diagnostics